newsfilter
← Latest News
Earnings Call Transcripts·

Kyverna AAN Conference Call - KYVERNA THERAPEUTICS INC

Good morning and thank you for joining us today. We will be discussing the primary analysis from our KAISA-8 Registrational Trial of Mevocaptogen Avalucel or MEVCEL, formerly referred to as KYV-101 and Stiff Person Syndr

Company
KYVERNA THERAPEUTICS INC
Keywords
KYVERNA THERAPEUTICS INC